Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000821247 | SCV000962000 | likely benign | Glycogen storage disease, type II | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372343 | SCV002686656 | likely benign | Cardiovascular phenotype | 2019-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000821247 | SCV002092006 | uncertain significance | Glycogen storage disease, type II | 2021-03-22 | no assertion criteria provided | clinical testing |